AI-powered bioactive peptide discovery company Lembas supports metabolism, appetite regulation and weight management with science-backed, food-grade bioactives, and its GLP-1 Edge can be integrated into multiple formats like gummies, powder, bars, shakes, and capsules.

While GLP-1 pharmaceuticals are on the rise, many remain inaccessible. In response, the food and supplement industries are stepping up with alternative ways to activate GLP-1, the hormone that helps regulate appetite and metabolism. GLP-1 Edge was made to naturally regulate appetite by enhancing the body’s own GLP-1 response. “At Lembas, we’re creating a new category of science-backed nutrition, empowering consumers for the first time to effectively and conveniently manage their weight through companion food and supplements without pricy prescriptions, injections, and unpleasant side effects,” said Shay Hilel, Co-Founder and CEO of Lembas.